0B68 Ju, Xiaoming - Thomas Jefferson University - Thomas Jefferson University
xxj006

Xiaoming Ju, MD

Contact Dr. Ju

Kimmel Cancer Center
233 S. Tenth Street, Suite 1028
Philadelphia, PA 19107

(215) 503-9354
(215) 923-4498 fax

Most Recent Peer-reviewed Publications

  1. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
  2. miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
  3. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer
  4. Dual fluorescent molecular substrates selectively report the activation, sustainability and reversibility of cellular PKB/Akt activity
  5. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures
  6. The canonical NF-κB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion
  7. C-jun inhibits mammary apoptosis in vivo
  8. New roles of hRAD21 in alternative lengthening of telomeres in cancer genesis
  9. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like ge 0E59 ne expression in vivo
  10. Nuclear factor-κB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo
  11. ErbB2 induces Notch1 activity and function in breast cancer cells
  12. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation
  13. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8
  14. Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase
  15. Akt1 governs breast cancer progression in vivo
  16. Cyclin D1 induction of cellular migration requires p27KIP1
  17. Cyclin D1 determines mitochondrial function in vivo
  18. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling
0